Traynor Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Traynor Capital Management's GILD Position: Q3 2019 in Review
Traynor Capital Management sold out of Gilead Sciences (GILD) in Q3 2019, closing a stake of 6,219 shares — an estimated $421K sold.
Traynor Capital Management first reported a position in GILD in Q4 2014 and held it in 19 quarters. The position peaked at $2.31M in Q1 2017. 1,462 funds tracked by Wall St. Rank hold GILD as of Q3 2019.
- Traynor Capital Management reported no remaining Gilead Sciences position as of Q3 2019 after selling out during the quarter.
- Traynor Capital Management sold 6,219 Gilead Sciences shares in Q3 2019, an estimated $421K.
- Traynor Capital Management first reported a position in Gilead Sciences in Q4 2014 and held it in 19 quarters.
- Traynor Capital Management's Gilead Sciences position peaked at $2.31M in Q1 2017.
- 1,462 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2019.
Based on Traynor Capital Management's 13F filing for Q3 2019, filed 1 Nov 2019.